Selling Shareholders Launch 75 Million Class A Share Secondary Offering
Selling shareholders including Blackstone, Carlyle, Hellman & Friedman and ADIA are offering 75 million Class A shares of Medline, plus a 30-day option for another 11.25 million shares. Medline will not sell shares or receive proceeds, while Goldman Sachs, Morgan Stanley, BofA Securities and J.P. Morgan manage the underwritten offering.
1. Offering Details
A consortium of selling shareholders has commenced an underwritten public offering of 75 million Class A shares of Medline, with underwriters granted a 30-day option to purchase up to an additional 11.25 million shares, expanding the company’s available float.
2. Sellers and Proceeds
The shares are being sold by affiliates of Blackstone, The Carlyle Group, Hellman & Friedman and a subsidiary of the Abu Dhabi Investment Authority. Medline itself is not selling any shares and will receive no proceeds from this transaction.
3. Underwriting Team
Goldman Sachs, Morgan Stanley, BofA Securities and J.P. Morgan serve as global coordinators and joint bookrunning managers. Blackstone Capital Markets and Carlyle are acting as co-managers for the secondary offering.
4. Market Implications
The sizeable secondary offering and potential over-allotment could put downward pressure on Medline’s share price by increasing supply, though no capital is raised for corporate use and fundamentals remain unchanged.